190 related articles for article (PubMed ID: 12635545)
1. [Sarcoidosis: immunopathogenesis and the potential of immunotherapy].
Gras M; van Kemenade FJ; van Maarsseveen AC; Alberts C
Ned Tijdschr Geneeskd; 2003 Jan; 147(4):150-5. PubMed ID: 12635545
[TBL] [Abstract][Full Text] [Related]
2. [Management of severe skin disorders in sarcoidosis].
Rybojad M
Ann Med Interne (Paris); 2001 Mar; 152(2):89-95. PubMed ID: 11357044
[TBL] [Abstract][Full Text] [Related]
3. [Sarcoidosis: immunopathology and criteria of biological activity].
Müller-Quernheim J; Ménard O
Rev Mal Respir; 1995; 12(6):525-31. PubMed ID: 8677346
[TBL] [Abstract][Full Text] [Related]
4. Clinical aspects and immune reactions in sarcoidosis.
Grunewald J
Clin Respir J; 2007 Dec; 1(2):64-73. PubMed ID: 20298284
[TBL] [Abstract][Full Text] [Related]
5. Review for disease of the year: immunopathogenesis of ocular sarcoidosis.
Chan AS; Sharma OP; Rao NA
Ocul Immunol Inflamm; 2010 Jun; 18(3):143-51. PubMed ID: 20482386
[TBL] [Abstract][Full Text] [Related]
6. [Pathogeny-etiology of sarcoidosis].
Soler P
Ann Med Interne (Paris); 2001 Feb; 152(1):28-33. PubMed ID: 11240423
[TBL] [Abstract][Full Text] [Related]
7. Treatment of sarcoidosis.
Lazar CA; Culver DA
Semin Respir Crit Care Med; 2010 Aug; 31(4):501-18. PubMed ID: 20665400
[TBL] [Abstract][Full Text] [Related]
8. [Sarcoidosis treatment].
Nunes H; Uzunhan Y; Bonnet D; Valeyre D
Rev Prat; 2008 May; 58(10):1099-104. PubMed ID: 18652410
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences.
Kormeili T; Lowe NJ; Yamauchi PS
Br J Dermatol; 2004 Jul; 151(1):3-15. PubMed ID: 15270867
[TBL] [Abstract][Full Text] [Related]
10. Sarcoidosis and its ocular manifestations.
Silver MR; Messner LV
J Am Optom Assoc; 1994 May; 65(5):321-7. PubMed ID: 8071502
[TBL] [Abstract][Full Text] [Related]
11. Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.
Grunewald J; Spagnolo P; Wahlström J; Eklund A
Clin Rev Allergy Immunol; 2015 Aug; 49(1):19-35. PubMed ID: 25791751
[TBL] [Abstract][Full Text] [Related]
12. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts.
Sweiss NJ; Curran J; Baughman RP
Clin Dermatol; 2007; 25(3):341-6. PubMed ID: 17560312
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary sarcoidosis: diagnostic and treatment update.
Fahim A; Mann JS
Expert Rev Respir Med; 2014 Aug; 8(4):493-501. PubMed ID: 24832794
[TBL] [Abstract][Full Text] [Related]
15. Sarcoidosis.
Johns CJ; Scott PP; Schonfeld SA
Annu Rev Med; 1989; 40():353-71. PubMed ID: 2524994
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous sarcoidosis: the "great imitator": etiopathogenesis, morphology, differential diagnosis, and clinical management.
Tchernev G
Am J Clin Dermatol; 2006; 7(6):375-82. PubMed ID: 17173472
[TBL] [Abstract][Full Text] [Related]
17. Mandibular sarcoidosis: case presentation.
Krajekian J; Goode R; Papageorge MB
J Mass Dent Soc; 2002; 51(2):52-5. PubMed ID: 12108124
[TBL] [Abstract][Full Text] [Related]
18. Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expression.
Sthoeger ZM; Sharabi A; Molad Y; Asher I; Zinger H; Dayan M; Mozes E
J Autoimmun; 2009 Aug; 33(1):77-82. PubMed ID: 19346102
[TBL] [Abstract][Full Text] [Related]
19. [Iris granulomas of unknown aetiology].
Zinkernagel M; Zografos L; Rüesch R
Klin Monbl Augenheilkd; 2007 Apr; 224(4):347-9. PubMed ID: 17458811
[TBL] [Abstract][Full Text] [Related]
20. Advances in understanding the immunopathology of sarcoidosis and implications on therapy.
Cinetto F; Agostini C
Expert Rev Clin Immunol; 2016 Sep; 12(9):973-88. PubMed ID: 27101234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
